These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 35483649)

  • 21. Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults.
    Murray CH; Tare I; Perry CM; Malina M; Lee R; de Wit H
    Psychopharmacology (Berl); 2022 Jun; 239(6):1735-1747. PubMed ID: 34613430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beyond LSD: A Broader Psychedelic Zeitgeist during the Early to Mid-20
    Aday JS; Bloesch EK; Davoli CC
    J Psychoactive Drugs; 2019; 51(3):210-217. PubMed ID: 30836890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychedelic drugs for psychiatric disorders.
    da Costa SC; Oesterle T; Rummans TA; Richelson E; Gold M
    J Neurol Sci; 2022 Sep; 440():120332. PubMed ID: 35841696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute effects of lysergic acid diethylamide (LSD) on resting brain function.
    Müller F; Borgwardt S
    Swiss Med Wkly; 2019 Sep; 149():w20124. PubMed ID: 31568558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Default Mode Network Modulation by Psychedelics: A Systematic Review.
    Gattuso JJ; Perkins D; Ruffell S; Lawrence AJ; Hoyer D; Jacobson LH; Timmermann C; Castle D; Rossell SL; Downey LA; Pagni BA; Galvão-Coelho NL; Nutt D; Sarris J
    Int J Neuropsychopharmacol; 2023 Mar; 26(3):155-188. PubMed ID: 36272145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets.
    Sousa TR; Rema J; Machado S; Novais F
    Curr Top Med Chem; 2022; 22(15):1250-1260. PubMed ID: 34852736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced repertoire of brain dynamical states during the psychedelic experience.
    Tagliazucchi E; Carhart-Harris R; Leech R; Nutt D; Chialvo DR
    Hum Brain Mapp; 2014 Nov; 35(11):5442-56. PubMed ID: 24989126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention.
    Barrett FS; Krimmel SR; Griffiths RR; Seminowicz DA; Mathur BN
    Neuroimage; 2020 Sep; 218():116980. PubMed ID: 32454209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neural Mechanisms of Resting-State Networks and the Amygdala Underlying the Cognitive and Emotional Effects of Psilocybin.
    Stoliker D; Novelli L; Vollenweider FX; Egan GF; Preller KH; Razi A
    Biol Psychiatry; 2024 Jul; 96(1):57-66. PubMed ID: 38185235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LSD modulates music-induced imagery via changes in parahippocampal connectivity.
    Kaelen M; Roseman L; Kahan J; Santos-Ribeiro A; Orban C; Lorenz R; Barrett FS; Bolstridge M; Williams T; Williams L; Wall MB; Feilding A; Muthukumaraswamy S; Nutt DJ; Carhart-Harris R
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1099-109. PubMed ID: 27084302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances and challenges in neuroimaging studies on the effects of serotonergic hallucinogens: Contributions of the resting brain.
    Müller F; Liechti ME; Lang UE; Borgwardt S
    Prog Brain Res; 2018; 242():159-177. PubMed ID: 30471679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.
    Le GH; Wong S; Badulescu S; Au H; Di Vincenzo JD; Gill H; Phan L; Rhee TG; Ho R; Teopiz KM; Kwan ATH; Rosenblat JD; Mansur RB; McIntyre RS
    J Affect Disord; 2024 Jun; 355():342-354. PubMed ID: 38570038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cessation and reduction in alcohol consumption and misuse after psychedelic use.
    Garcia-Romeu A; Davis AK; Erowid F; Erowid E; Griffiths RR; Johnson MW
    J Psychopharmacol; 2019 Sep; 33(9):1088-1101. PubMed ID: 31084460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effective connectivity changes in LSD-induced altered states of consciousness in humans.
    Preller KH; Razi A; Zeidman P; Stämpfli P; Friston KJ; Vollenweider FX
    Proc Natl Acad Sci U S A; 2019 Feb; 116(7):2743-2748. PubMed ID: 30692255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action.
    Dos Santos RG; Hallak JE; Baker G; Dursun S
    J Psychopharmacol; 2021 Apr; 35(4):453-458. PubMed ID: 33740877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neural correlates of the LSD experience revealed by multimodal neuroimaging.
    Carhart-Harris RL; Muthukumaraswamy S; Roseman L; Kaelen M; Droog W; Murphy K; Tagliazucchi E; Schenberg EE; Nest T; Orban C; Leech R; Williams LT; Williams TM; Bolstridge M; Sessa B; McGonigle J; Sereno MI; Nichols D; Hellyer PJ; Hobden P; Evans J; Singh KD; Wise RG; Curran HV; Feilding A; Nutt DJ
    Proc Natl Acad Sci U S A; 2016 Apr; 113(17):4853-8. PubMed ID: 27071089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain's control energy landscape.
    Singleton SP; Luppi AI; Carhart-Harris RL; Cruzat J; Roseman L; Nutt DJ; Deco G; Kringelbach ML; Stamatakis EA; Kuceyeski A
    Nat Commun; 2022 Oct; 13(1):5812. PubMed ID: 36192411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spatial Correspondence of LSD-Induced Variations on Brain Functioning at Rest With Serotonin Receptor Expression.
    Delli Pizzi S; Chiacchiaretta P; Sestieri C; Ferretti A; Onofrj M; Della Penna S; Roseman L; Timmermann C; Nutt DJ; Carhart-Harris RL; Sensi SL
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2023 Jul; 8(7):768-776. PubMed ID: 37003409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human behavioral pharmacology of psychedelics.
    Strickland JC; Johnson MW
    Adv Pharmacol; 2022; 93():105-132. PubMed ID: 35341564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis.
    Leger RF; Unterwald EM
    J Psychopharmacol; 2022 Jan; 36(1):20-30. PubMed ID: 34519567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.